Article Detail - JE Part B
Billing and Coding: MolDX: Prostate Cancer Genomic Classifier Assay for Men with Localized Disease - R3 - Effective December 06, 2020
This coverage article has been revised and published for notice under contract numbers: 01112 (NCA), 01182 (SCA), 01212 (AS, GU, HI, NMI), and 01312 (NV).
Effective Date: December 06, 2020
Summary of Article Changes: Under CPT/HCPCS Codes Group 1: Codes added 0047U. This revision is retroactive effective for dates of service on or after 12/06/20.
Visit the Molecular Diagnostic Services (MolDX) webpage to access the locally hosted MolDX Medicare Coverage Article from the “Covered Tests” or the “Excluded Tests” webpage.
To view the complete listing of locally hosted coverage articles and/or access the Active, Future, or Retired articles available in the CMS MCD, visit the Medicare Coverage Articles webpage.
Last Updated Tue, 23 Nov 2021 15:20:16 +0000